Skip to content

Clinical trials

Sarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Clear all

1,601 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200029
200133
200220
200328
200442
200549
200644
200748
200838
200939
201055
201151
201247
201330
201442
201558
201664
201775
201865
201981
202090
202183
202270
202372
202470
202586
202672

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed742
Recruiting264
Terminated179
Unknown status160
Active, not recruiting116
Withdrawn61
Not yet recruiting50
Suspended9
Enrolling by invitation7
No longer available6
Available6
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)115
Memorial Sloan Kettering Cancer Center64
M.D. Anderson Cancer Center47
Children's Oncology Group44
European Organisation for Research and Treatment of Cancer - EORTC22
Institut Bergonié22
Dana-Farber Cancer Institute19
Washington University School of Medicine19
University Health Network, Toronto18
Mayo Clinic17

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma1,601
Osteosarcoma193
Breast Neoplasms182
Melanoma170
Ovarian Neoplasms165
Neoplasms162
Rhabdomyosarcoma124
Neuroblastoma120
Colorectal Neoplasms105
Pancreatic Neoplasms104

Trials

Showing 26 to 50 of 1,601. Each trial links to its page on Pharma Observatory.

1,501 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.